TP53 and soft tissue sarcoma: Based on tumor types, 3.37% of p53-positive cases were in mammary carcinomas, 26.08% in squamous cell carcinomas, 15.78% in soft tissue sarcomas, 10.52% in amelanotic melanomas, and 4.54% in mast cell tumors.